Newly-released Cardiovascular Ultrasound Market analysis report by Future Market Insights shows that global revenue in the Cardiovascular Ultrasound Market in 2022 was held at US$ 1.2 Billion. With a CAGR of 7.2% from 2023 to 2033, the market is expected to reach a US$ 2.6 billion valuation by 2033. Transthoracic Echocardiography is expected to be the highest revenue-generating segment, accounting for an expected CAGR rate of 7.3% from 2023 to 2033.
| Attribute | Details |
|---|---|
| Global Cardiovascular Ultrasound Market (2023) | US$ 1.3 Billion |
| Global Cardiovascular Ultrasound Market CAGR (2023 to 2033) | 7.2% |
| Global Cardiovascular Ultrasound Market (2033) | US$ 2.6 Billion |
| USA Cardiovascular Ultrasound Market (2033) | US$ 641 Million |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The growing inclination for non-invasive diagnostic procedures is driving the global cardiovascular ultrasound market. Furthermore, manufacturers' increasing focus on developing creative and revolutionary cardiovascular ultrasound systems would be a prominent factor affecting the market growth. The rising geriatric population and an increase in the number of government agencies spreading awareness are prominent factors boosting the growth of the cardiovascular ultrasound system market.
In addition, changing lifestyles and rising healthcare infrastructure spending are the key market drivers that will propel the cardiovascular ultrasound system market forward.
Because of the rise in preventive medicine and the increased acceptance of modern technologies in the region, North America dominates the cardiovascular ultrasound system market as a result of enhanced healthcare infrastructure and the widespread use of CVUS in preventive medicine.
Principal Consultant
Medicare payments are based on a variety of criteria in the USA, including relative value units, conversion factors, and local practice cost indexes. The medicare program has new laws that govern reimbursement policies. Over the projected period, the favorable reimbursement policy and regulatory frameworks are expected to aid market expansion in the country.
The market in the United kingdom is expected to reach a valuation of US$ 121.5 Million by 2033. Growing with a CAGR of 8.3% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of US$ 26.8 Million.
In Japan, the market is expected to grow at a CAGR of 9.3% from 2023 to 2033, reaching US$ 128.3 Million by 2033. The market in the country is expected to gross an absolute dollar opportunity of US$ 75.3 Million during the forecast period.
The cardiovascular ultrasound market through transthoracic echocardiography accounted for a significant market in 2022. During the projected period, the transthoracic echocardiography segment is expected to grow at the fastest rate of 7.3%.
Fetal echocardiography is a pregnancy test that is conducted in the second trimester to determine whether the fetus has developed all four chambers of the heart. It allows seeing the heart anatomy of an unborn child. The expansion of this market is being fuelled by rising levels of awareness concerning fetus health.
Doppler is the prominent cardiovascular ultrasound system as it produces clear images in less time Doppler accounted for the largest revenue share in 2020. Due to the rising prevalence of technologically advanced systems in developing nations like India and China, the technique is gaining traction.
Doppler echocardiography is a non-invasive method for measuring blood flow within the heart. Radcliffe Cardiology also ran a workshop on two-dimensional echocardiography in Vail in March 2019. The specific use of Doppler ultrasound for hemodynamics and cardiac function, in addition to its use in hemodynamics, such as valvular heart disease, were among the topics they covered. As a result, improvements in Doppler technology to improve cardiac imaging are likely to drive category growth.
The color cardiovascular ultrasound systems segment held a prominent revenue share in the recent past. Due to the clarity of images offered by color systems, they are generally chosen over B/W systems. Furthermore, color cardiovascular ultrasonography aids in accurate diagnosis. Hitachi offers a number of color systems that are available globally.
Owing to these factors, the color systems segment is expected to grow at a significant pace throughout the projected period. The 2D, 3D/4D, and Doppler ultrasound equipment can be used with B/W systems. B/W devices are used by many notable companies, including Siemens Healthcare and Philips Healthcare. To switch to color mode, these gadgets are employed in health clinics with limited budgets.
Market revenue through hospitals accounts for a significant share. Since medical imaging is a significant source of outpatient revenue, a number of mid to large-sized hospitals have medical imaging equipment installed on their grounds.
Medical imaging facilities are available mostly at large-scale hospitals. Medical imaging centers, on the other hand, demand significant upkeep, space, and qualified personnel. These issues add to the hospital's financial burden in administering such facilities. As a result, hospitals choose to cooperate with diagnostic centers to provide medical imaging services. This saves money, especially in small and medium-sized hospitals.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the prominent players in the cardiovascular ultrasound market include GE Healthcare, Koninklijke Philips, Siemens Healthineers AG, Hitachi Medical Corp., Samsung Medison Co. Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Chison Wuxi Xiangsheng Medical Technology Co., Ltd., and Fujifilm Sonosite, Inc.
Some of the recent developments of key Cardiovascular Ultrasound providers are as follows:
Similarly, recent developments related to companies offering Cardiovascular Ultrasound have been tracked by the team at Future Market Insights, which is available in the full report.
North America
Latin America
Europe
Asia Pacific Excluding Japan (APAC)
Middle East & Africa (MEA)
During 2018 to 2022, the market registered a CAGR of 7.3%.
The market is estimated to reach US$ 2.6 billion by 2033.
Hospital sector holds high revenue potential.
The United States, Japan, and the United Kingdom dominate the global market.
The market is forecast to register a CAGR of 7.2% through 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Future Market Insight Analysis and Recommendations 2. Market Overview 2.1. Market Coverage 2.2. Market Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Cardiovascular Ultrasound 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Billion) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background 4.1. Market, by Key Countries 4.2. Market Opportunity Assessment (US$ Billion) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Growth in Automation, By Country 4.5.3. Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Analysis, 2018 to 2022 6.2. Current and Future Market Projections, 2023 to 2033 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033 7.1. Historical Market Value (US$ Billion) Analysis, 2018 to 2022 7.2. Current and Future Market Value (US$ Billion) Projections, 2023 to 2033 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Billion) Analysis By Type, 2018 to 2022 8.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Type, 2023 to 2033 8.3.1. Fetal Echoocardiography 8.3.2. Transthoracic Echocardiography 8.3.3. Transesophageal Echocardiography 8.3.4. Others 8.4. Market Attractiveness Analysis By Type 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Billion) Analysis By Technology, 2018 to 2022 9.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Technology, 2023 to 2033 9.3.1. 2D 9.3.2. 3D/4D 9.3.3. Doppler 9.4. Market Attractiveness Analysis By Technology 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Display Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Billion) Analysis By Display Type, 2018 to 2022 10.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Display Type, 2023 to 2033 10.3.1. B/W 10.3.2. Color 10.4. Market Attractiveness Analysis By Display Type 11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-use 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Billion) Analysis By End-use, 2018 to 2022 11.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By End-use, 2023 to 2033 11.3.1. Hospitals 11.3.2. Diagnostic Centres 11.3.3. Ambulatory Care Centers 11.3.4. Other End-Uses 11.4. Market Attractiveness Analysis By End-use 12. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 12.1. Introduction 12.2. Historical Market Size (US$ Billion) Analysis By Region, 2018 to 2022 12.3. Current Market Size (US$ Billion) & Analysis and Forecast By Region, 2023 to 2033 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. APAC 12.3.5. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Value (US$ Billion) Trend Analysis By Market Taxonomy, 2018 to 2022 13.4. Market Value (US$ Billion) & Forecast By Market Taxonomy, 2023 to 2033 13.4.1. By Country 13.4.1.1. USA 13.4.1.2. Canada 13.4.1.3. Rest of North America 13.4.2. By Type 13.4.3. By Technology 13.4.4. By End-use 13.4.5. By Display Type 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Type 13.5.3. By Technology 13.5.4. By End-use 13.5.5. By Display Type 14. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Value (US$ Billion) Trend Analysis By Market Taxonomy, 2018 to 2022 14.4. Market Value (US$ Billion) & Forecast By Market Taxonomy, 2023 to 2033 14.4.1. By Country 14.4.1.1. Brazil 14.4.1.2. Mexico 14.4.1.3. Rest of Latin America 14.4.2. By Type 14.4.3. By Technology 14.4.4. By End-use 14.4.5. By Display Type 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Type 14.5.3. By Technology 14.5.4. By End-use 14.5.5. By Display Type 15. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Value (US$ Billion) Trend Analysis By Market Taxonomy, 2018 to 2022 15.4. Market Value (US$ Billion) & Forecast By Market Taxonomy, 2023 to 2033 15.4.1. By Country 15.4.1.1. Germany 15.4.1.2. France 15.4.1.3. United Kingdom 15.4.1.4. Italy 15.4.1.5. Spain 15.4.1.6. Netherlands 15.4.1.7. Rest of Europe 15.4.2. By Type 15.4.3. By Technology 15.4.4. By End-use 15.4.5. By Display Type 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Type 15.5.3. By Technology 15.5.4. By End-use 15.5.5. By Display Type 16. APAC Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Value (US$ Billion) Trend Analysis By Market Taxonomy, 2018 to 2022 16.4. Market Value (US$ Billion) & Forecast By Market Taxonomy, 2023 to 2033 16.4.1. By Country 16.4.1.1. China 16.4.1.2. Japan 16.4.1.3. South Korea 16.4.1.4. Rest of APAC 16.4.2. By Type 16.4.3. By Technology 16.4.4. By End-use 16.4.5. By Display Type 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Type 16.5.3. By Technology 16.5.4. By End-use 16.5.5. By Display Type 17. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Value (US$ Billion) Trend Analysis By Market Taxonomy, 2018 to 2022 17.4. Market Value (US$ Billion) & Forecast By Market Taxonomy, 2023 to 2033 17.4.1. By Country 17.4.1.1. Saudi Arabia 17.4.1.2. South Africa 17.4.1.3. UAE 17.4.1.4. Rest of Middle East and Africa 17.4.2. By Type 17.4.3. By Technology 17.4.4. By End-use 17.4.5. By Display Type 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Type 17.5.3. By Technology 17.5.4. By End-use 17.5.5. By Display Type 18. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.1.1. Market Value Proportion Analysis, By Key Countries 18.1.2. Global Vs. Country Growth Comparison 18.2. US Market Analysis 18.2.1. Value Proportion Analysis by Market Taxonomy 18.2.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033 18.2.2.1. By Type 18.2.2.2. By Technology 18.2.2.3. By End-use 18.2.2.4. By Display Type 18.3. Canada Market Analysis 18.3.1. Value Proportion Analysis by Market Taxonomy 18.3.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033 18.3.2.1. By Type 18.3.2.2. By Technology 18.3.2.3. By End-use 18.3.2.4. By Display Type 18.4. Mexico Market Analysis 18.4.1. Value Proportion Analysis by Market Taxonomy 18.4.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033 18.4.2.1. By Type 18.4.2.2. By Technology 18.4.2.3. By End-use 18.4.2.4. By Display Type 18.5. Brazil Market Analysis 18.5.1. Value Proportion Analysis by Market Taxonomy 18.5.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033 18.5.2.1. By Type 18.5.2.2. By Technology 18.5.2.3. By End-use 18.5.2.4. By Display Type 18.6. Germany Market Analysis 18.6.1. Value Proportion Analysis by Market Taxonomy 18.6.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033 18.6.2.1. By Type 18.6.2.2. By Technology 18.6.2.3. By End-use 18.6.2.4. By Display Type 18.7. France Market Analysis 18.7.1. Value Proportion Analysis by Market Taxonomy 18.7.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033 18.7.2.1. By Type 18.7.2.2. By Technology 18.7.2.3. By End-use 18.7.2.4. By Display Type 18.8. Italy Market Analysis 18.8.1. Value Proportion Analysis by Market Taxonomy 18.8.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033 18.8.2.1. By Type 18.8.2.2. By Technology 18.8.2.3. By End-use 18.8.2.4. By Display Type 18.9. Spain Market Analysis 18.9.1. Value Proportion Analysis by Market Taxonomy 18.9.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033 18.9.2.1. By Type 18.9.2.2. By Technology 18.9.2.3. By End-use 18.9.2.4. By Display Type 18.10. UK Market Analysis 18.10.1. Value Proportion Analysis by Market Taxonomy 18.10.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033 18.10.2.1. By Type 18.10.2.2. By Technology 18.10.2.3. By End-use 18.10.2.4. By Display Type 18.11. Netherlands Market Analysis 18.11.1. Value Proportion Analysis by Market Taxonomy 18.11.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033 18.11.2.1. By Type 18.11.2.2. By Technology 18.11.2.3. By End-use 18.11.2.4. By Display Type 18.12. China Market Analysis 18.12.1. Value Proportion Analysis by Market Taxonomy 18.12.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033 18.12.2.1. By Type 18.12.2.2. By Technology 18.12.2.3. By End-use 18.12.2.4. By Display Type 18.13. Japan Market Analysis 18.13.1. Value Proportion Analysis by Market Taxonomy 18.13.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033 18.13.2.1. By Type 18.13.2.2. By Technology 18.13.2.3. By End-use 18.13.2.4. By Display Type 18.14. South Korea Market Analysis 18.14.1. Value Proportion Analysis by Market Taxonomy 18.14.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033 18.14.2.1. By Type 18.14.2.2. By Technology 18.14.2.3. By End-use 18.14.2.4. By Display Type 18.15. Saudi Arabia Market Analysis 18.15.1. Value Proportion Analysis by Market Taxonomy 18.15.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033 18.15.2.1. By Type 18.15.2.2. By Technology 18.15.2.3. By End-use 18.15.2.4. By Display Type 18.16. South Africa Market Analysis 18.16.1. Value Proportion Analysis by Market Taxonomy 18.16.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033 18.16.2.1. By Type 18.16.2.2. By Technology 18.16.2.3. By End-use 18.16.2.4. By Display Type 18.17. UAE Market Analysis 18.17.1. Value Proportion Analysis by Market Taxonomy 18.17.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033 18.17.2.1. By Type 18.17.2.2. By Technology 18.17.2.3. By End-use 18.17.2.4. By Display Type 18.17.3. Competition Landscape and Player Concentration in the Country 19. Market Structure Analysis 19.1. Market Analysis by Tier of Companies 19.2. Market Concentration 19.3. Market Share Analysis of Top Players 19.4. Market Presence Analysis 19.4.1. By Regional footprint of Players 19.4.2. Product footprint by Players 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep Dive 20.3.1. GE Healthcare 20.3.1.1. Overview 20.3.1.2. Product Portfolio 20.3.1.3. Sales Footprint 20.3.1.4. Strategy Overview 20.3.2. Koninklijke Philips 20.3.2.1. Overview 20.3.2.2. Product Portfolio 20.3.2.3. Sales Footprint 20.3.2.4. Strategy Overview 20.3.3. Siemens Healthineers AG 20.3.3.1. Overview 20.3.3.2. Product Portfolio 20.3.3.3. Sales Footprint 20.3.3.4. Strategy Overview 20.3.4. Hitachi Medical Corp. 20.3.4.1. Overview 20.3.4.2. Product Portfolio 20.3.4.3. Sales Footprint 20.3.4.4. Strategy Overview 20.3.5. Samsung Medison Co. Ltd. 20.3.5.1. Overview 20.3.5.2. Product Portfolio 20.3.5.3. Sales Footprint 20.3.5.4. Strategy Overview 20.3.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Mindray) 20.3.6.1. Overview 20.3.6.2. Product Portfolio 20.3.6.3. Sales Footprint 20.3.6.4. Strategy Overview 20.3.7. Chison Wuxi Xiangsheng Medical Technology Co., Ltd. 20.3.7.1. Overview 20.3.7.2. Product Portfolio 20.3.7.3. Sales Footprint 20.3.7.4. Strategy Overview 20.3.8. Fujifilm Sonosite, Inc 20.3.8.1. Overview 20.3.8.2. Product Portfolio 20.3.8.3. Sales Footprint 20.3.8.4. Strategy Overview 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
Cardiovascular Ultrasound Market
